title: [Obstructive sleep apnoea syndrome].
abstract: Obstructive sleep apnoea (OSA) and other sleep disordered breathing are common disorders causing significant morbidity, mortality and societal burden. A significant proportion of the patients are undiagnosed and consequently untreated. Due to the wide disease distribution we recommend increased disease awareness, especially among high-risk groups: patients with obesity, metabolic syndrome and cardio- and cerebrovascular diseases. Continuous positive airway pressure (CPAP) is the first-line of treatment together with weight reduction, whereas oral devices may be used for less severe OSA or in cases where CPAP cannot be used.
authors.affiliation: Center for Søvnforstyrrelser, Klinisk Neurofysiologisk Afdeling, Glostrup Hospital, 2600 Glostrup. poul.jennum@regionh.dk.
authors.forename: Poul
authors.initials: P
authors.lastname: Jennum
authors.forename: Philip
authors.initials: P
authors.lastname: Tønnesen
mesh_terms: D006801:Humans; D012307:Risk Factors; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy